Seres Therapeutics, Inc. (MCRB)

Last Three Months

20-Feb-24 -- 19-May-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

20

0

2

+1

0

+2

0

+3

Two Year Chart

20-May-22 -- 19-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
17-May-24 8:14 PM View:	15-May-24 Planned Option Sale ($0.79K)	Desrosier Thomas Chief Legal Officer and EVP		Seres Therapeutics, Inc. - MCRB	2% 120.58K to 122.39K	0	0	--	--	Show Txns Hide Txns

17-May-24 8:17 PM View:	15-May-24 Planned Option Sale ($0.84K)	Henn Matthew R. See Remarks		Seres Therapeutics, Inc. - MCRB	3% 63.44K to 65.36K	0	0	--	--	Show Txns Hide Txns

17-May-24 8:23 PM View:	15-May-24 Planned Option Sale ($0.88K)	von Moltke Lisa See Remarks		Seres Therapeutics, Inc. - MCRB	12% 16.99K to 19.02K	0	0	--	--	Show Txns Hide Txns

17-May-24 8:18 PM View:	15-May-24 Planned Option Sale ($0.66K)	Young Teresa L. See Remarks		Seres Therapeutics, Inc. - MCRB	12% 15.71K to 17.66K	0	0	--	--	Show Txns Hide Txns

17-May-24 8:16 PM View:	15-May-24 Planned Option Sale ($1.02K)	Ege David S. See Remarks		Seres Therapeutics, Inc. - MCRB	3% 73.86K to 75.73K	0	0	--	--	Show Txns Hide Txns

17-May-24 8:18 PM View:	15-May-24 Planned Option Sale ($2.29K)	Shaff Eric D. CEO and President Director		Seres Therapeutics, Inc. - MCRB	4% 135.32K to 140.7K	0	0	--	--	Show Txns Hide Txns